Deep Dive

Industry insights from our journalists


  • Red human heart drawing on blue background
    Image attribution tooltip
    Jolygon via Getty Images
    Image attribution tooltip

    4 heart device trends shaping the medtech sector in 2024

    Medtronic, Boston Scientific and J&J are among the medtech companies advancing treatments in cardiac care for when medicines are not enough.

    Susan Kelly • Jan. 30, 2024
  • eight xray images side by side show rounded joints and pins in the hips and knees
    Image attribution tooltip
    real444 via Getty Images
    Image attribution tooltip

    Orthopedics leaders watch procedure backlog, new technologies in 2024

    J&J, Medtronic and Smith & Nephew executives and orthopedic surgeons said they expect more procedures to move outpatient, while questions about pricing and procedure backlogs loom over the medical technology industry. 

    Elise Reuter • Jan. 23, 2024
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    5 medtech trends to watch in 2024

    From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.

    Ricky Zipp • Jan. 9, 2024
  • A needle is seen piercing a cell membrane in a composite image behind an office building.
    Image attribution tooltip

    Photo illustration: Shaun Lucas/Industry Dive; CRISPR Therapeutics; Gregor Fischer/DPA/Newscom

    Image attribution tooltip

    ‘No tolerance for failure’: An oral history of the first CRISPR medicine

    A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. and U.K. This is the story of how it came to be.

    Ned Pagliarulo and Shaun Lucas • Dec. 13, 2023
  • A silhouetted hand holds a syringe.
    Image attribution tooltip

    Matt Rourke/AP

    Image attribution tooltip

    Why medical device companies are worried about the EPA’s planned sterilization regs

    The EPA is expected to finalize new regulations in March that would limit ethylene oxide emissions from companies that sterilize medical devices.

    Elise Reuter and Shaun Lucas • Nov. 27, 2023
  • A person speaks in front of a screen showing four cards that read: Lingo Glucose, Lingo Ketone, Lingo Lactate and Lingo Alcohol
    Image attribution tooltip
    Ethan Miller via Getty Images
    Image attribution tooltip

    Why medtech firms are putting diabetes tech in consumer devices

    As Abbott develops a line of wearable wellness devices, and Dexcom makes a CGM for people with diabetes who don’t take insulin, both companies are turning to new users for future growth.

    Elise Reuter • Updated Aug. 31, 2023
  • Nick Jonas poses in front of a glowing background, wearing a small, round device on his upper arm
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom, Abbott ramp up DTC marketing amid fight for share of growing diabetes market

    As insurers cover continuous glucose monitors for more people, device-makers are taking a page from the pharma marketing playbook.

    Elise Reuter • Aug. 17, 2023
  • Masimo CEO Joe Kiani looks over the countryside
    Image attribution tooltip
    Courtesy of BusinessWire/Masimo
    Image attribution tooltip

    Showdown at Masimo: Proxy battle targets CEO Kiani’s leadership, board

    Shareholders are voting on whether to add investor Politan Capital’s picks to the board of the pulse oximeter maker, a move that could change the company’s direction.

    Susan Kelly • June 23, 2023
  • Two smartphones with a smart watch in between show glucose levels, active insulin, and carb entries from a meal.
    Image attribution tooltip
    Permission granted by Tidepool
    Image attribution tooltip

    Grassroots innovation: How a patient-driven device for diabetes won FDA clearance

    Tidepool Loop, an automated insulin dosing app based on one developed by the DIY diabetes community, received FDA clearance in January. 

    Elise Reuter • April 3, 2023
  • A person holds a transparent, oval shaped device
    Image attribution tooltip
    webphotographeer via Getty Images
    Image attribution tooltip

    Delays in reporting led FDA to late cancer warning on breast implants, advocates say

    Cases need to be better tracked, and the cancer risks should be discussed with patients prior to surgery, patient advocates and physicians said.

    Elise Reuter • March 22, 2023
  • A glucometer, insulet pen and syringes on a blue background
    Image attribution tooltip
    Volodymyr Bushmelov via Getty Images
    Image attribution tooltip

    Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

    From new product launches to regulatory changes that could expand CGM coverage, company executives and analysts share their predictions.

    Elise Reuter • Jan. 20, 2023
  • road sign shows two arrows merging
    Image attribution tooltip
    ryasick via Getty Images
    Image attribution tooltip

    A look back at medtech’s top 10 acquisitions of 2022

    While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.

    Elise Reuter • Dec. 22, 2022
  • Masimo W1 offers accurate, continuous health data and actionable health insights – from the leader in hospital pulse oximetry – in a personal, lifestyle-friendly watch. Building on Masimo’s decades of
    Image attribution tooltip
    Courtesy of Masimo
    Image attribution tooltip

    Apple locked in court battles with small medtech firms over allegations of stolen technology

    AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.

    Elise Reuter and Nick Paul Taylor • Updated Dec. 13, 2022
  • A picture of the street sign stating "Wall Street." American flags drape over a nearby building
    Image attribution tooltip
    Kena Betancur via Getty Images
    Image attribution tooltip

    Health tech companies weigh options to stem cash burn as IPO market sags

    Healthcare technology companies are delaying initial share sales as public market stocks and valuations plunge across the sector. Where will they turn in the meantime?

    Sydney Halleman • Updated Nov. 24, 2022
  • Exterior view of a building that says Integrated Surgical Services on the front.
    Image attribution tooltip
    Permission granted by Stryker
    Image attribution tooltip

    Medtech companies shift strategy as more orthopedic procedures move to ambulatory surgical centers

    Many ASCs are looking for cashless options to get capital equipment as they offset the cost of new buildings, Zimmer Biomet COO Ivan Tornos said.

    Elise Reuter • Oct. 5, 2022
  • A Covid testing site in New York
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    With COVID testing on the wane, small diagnostics companies shift focus

    Startups that grew quickly from large contracts are looking nervously to a new future, as demand plummets for mass testing and shifts to homes.

    Elise Reuter • July 13, 2022
  • Close up of a knee implant, showing the stem, which includes a gray extension.
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Companies see a future for smart implants. Doctors are waiting for proof.

    Zimmer Biomet and Canary Medical are rolling out the first knee implant with an integrated sensor, though it will take time to learn how to incorporate that data into patient care, experts say.

    Elise Reuter • June 28, 2022
  • The United States Capitol in February 2020
    Image attribution tooltip
    Megan Quinn/MedTech Dive
    Image attribution tooltip

    As cross-state telemedicine waivers expire, virtual care advocates focus on long-term policy changes

    There’s a complication: No one solution to the U.S.’ patchy physician licensing infrastructure has universal buy-in.

    Rebecca Pifer • June 22, 2022
  • A child plays EndeavorRx on a tablet. The digital therapeutic intended to improve attention in kids with ADHD.
    Image attribution tooltip
    Permission granted by Akili Interactive
    Image attribution tooltip

    Can digital therapeutics become profitable?

    As more software-based treatments gain FDA clearance, they still face hurdles ahead in getting insurance reimbursement and garnering adoption among patients and physicians.

    Elise Reuter • April 11, 2022
  • The sign identifying the FDA headquarters in front of its building in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    ‘Where’s the patient?’: Experts question FDA’s final recall guidance

    While the guidance encouraged the use of electronic communications in recalls — a change experts have advocated for — some questioned why the agency did not address more problems with the system.

    Ricky Zipp • April 6, 2022
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images
    Image attribution tooltip

    Hospitals struggle to fill staffing holes in short, long term amid surge in nurse turnover

    "This is a bigger workforce shortage than we have ever dealt with," said Gay Landstrom, senior vice president and chief nursing officer of Trinity Health, a nonprofit system with 88 hospitals nationwide.

    Hailey Mensik • March 31, 2022
  • Image attribution tooltip
    Diego Camargo/MedTech Dive
    Image attribution tooltip

    Long-term health of patients, hospitals at stake as care delays continue

    As federal relief funds dwindle and volumes remain stagnant, concerns are mounting about the stability of many providers' operations, especially those lacking robust outpatient services.

    Samantha Liss • March 30, 2022
  • Photo of exhibition hall floor, HIMSS22 in Orlando, March
    Image attribution tooltip
    Rebecca Pifer/MedTech Dive
    Image attribution tooltip

    The case for hybrid care models

    Telehealth is increasingly being woven into healthcare organizations' future plans, giving hope to proponents of hybrid care models.

    Rebecca Pifer • March 22, 2022
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images
    Image attribution tooltip

    Threats, obscenities, homicide: Healthcare workers stressed by pandemic face elevated violence

    Millions of healthcare workers across the country are becoming inured to workplace violence, which can range from verbal abuse and threats to physical attacks and even homicide.

    Hailey Mensik • March 9, 2022
  • Medtech, hospitals on alert for cyberattacks after Russia's invasion of Ukraine

    While cybersecurity threats to healthcare and medical devices have grown during the pandemic, the Russia-Ukraine conflict has raised the threat level, putting patient safety at risk.

    Greg Slabodkin • Feb. 28, 2022